HUT59013A - Process for producing stabilized aqueous compositions of small peptides - Google Patents
Process for producing stabilized aqueous compositions of small peptidesInfo
- Publication number
- HUT59013A HUT59013A HU907939A HU793990A HUT59013A HU T59013 A HUT59013 A HU T59013A HU 907939 A HU907939 A HU 907939A HU 793990 A HU793990 A HU 793990A HU T59013 A HUT59013 A HU T59013A
- Authority
- HU
- Hungary
- Prior art keywords
- aqueous compositions
- small peptides
- stabilized aqueous
- producing stabilized
- producing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41384189A | 1989-09-28 | 1989-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU907939D0 HU907939D0 (en) | 1991-08-28 |
HUT59013A true HUT59013A (en) | 1992-04-28 |
Family
ID=23638883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU907939A HUT59013A (en) | 1989-09-28 | 1990-09-18 | Process for producing stabilized aqueous compositions of small peptides |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0420649A3 (hu) |
JP (1) | JPH04502017A (hu) |
AU (1) | AU6446790A (hu) |
BR (1) | BR9006934A (hu) |
CA (1) | CA2026149A1 (hu) |
DD (1) | DD298053A5 (hu) |
HU (1) | HUT59013A (hu) |
IE (1) | IE903475A1 (hu) |
IL (1) | IL95663A0 (hu) |
IT (1) | IT1240314B (hu) |
NZ (1) | NZ235324A (hu) |
PT (1) | PT95451A (hu) |
WO (1) | WO1991004743A1 (hu) |
ZA (1) | ZA907492B (hu) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5036050A (en) * | 1989-01-12 | 1991-07-30 | Immunobiology Research Institute, Inc. | Compositions containing thymopentin for topical treatment of skin disorders |
US5834028A (en) * | 1993-12-17 | 1998-11-10 | Mochida Pharmaceutical Co., Ltd. | Soluble thrombomodulin-containing composition |
CA2192725C (en) | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Camptothecin derivatives |
ES2477996T3 (es) * | 2000-08-11 | 2014-07-18 | Chugai Seiyaku Kabushiki Kaisha | Preparaciones estabilizadas que contienen un anticuerpo |
US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
US7425618B2 (en) | 2002-06-14 | 2008-09-16 | Medimmune, Inc. | Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
WO2005012347A2 (en) | 2003-08-05 | 2005-02-10 | Novo Nordisk A/S | Novel insulin derivatives |
DE202004020676U1 (de) | 2004-03-10 | 2005-11-10 | Bioceuticals Arzneimittel Ag | Erythropoietin-Flüssigformulierung |
EP2505593A1 (en) | 2005-12-28 | 2012-10-03 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
CN101677947B (zh) | 2007-06-13 | 2013-07-17 | 诺沃-诺迪斯克有限公司 | 包含胰岛素衍生物的药物制剂 |
MX2011001620A (es) | 2008-08-15 | 2011-03-25 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para administracion oral. |
US9603904B2 (en) | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
US8329649B2 (en) | 2008-11-04 | 2012-12-11 | Aska Pharmaceutical Co., Ltd. | Aqueous composition containing follicle-stimulating hormone and histidine |
MX2012001660A (es) | 2009-08-06 | 2012-03-26 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para adminstracion oral. |
AR080428A1 (es) | 2010-01-20 | 2012-04-11 | Chugai Pharmaceutical Co Ltd | Formulaciones liquidas estabilizadas contentivas de anticuerpos |
CA2790213A1 (en) | 2010-02-17 | 2011-08-25 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
WO2012021715A2 (en) | 2010-08-11 | 2012-02-16 | Ironwood Pharmaceuticals, Inc. | Stable formulations of linaclotide |
JP6049625B2 (ja) | 2010-10-27 | 2016-12-21 | ノヴォ ノルディスク アー/エス | 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療 |
BR112013026883A2 (pt) | 2011-04-20 | 2021-12-07 | Sandoz Ag | Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica |
EP2776055B1 (en) | 2011-08-17 | 2016-12-14 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
US10485869B2 (en) | 2011-10-18 | 2019-11-26 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with meglumine |
PL2768525T3 (pl) | 2011-10-18 | 2019-10-31 | Coherus Biosciences Inc | Preparaty etanerceptu stabilizowane jonami magnezu |
AU2013315750B9 (en) | 2012-09-11 | 2018-11-15 | Coherus Biosciences, Inc. | Correctly folded etanercept in high purity and excellent yield |
US10137172B2 (en) | 2013-04-30 | 2018-11-27 | Novo Nordisk A/S | Administration regime |
CN105012232B (zh) * | 2015-08-14 | 2017-09-05 | 北京世桥生物制药有限公司 | 一种胸腺五肽注射液及其制作方法 |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
WO2023017537A1 (en) | 2021-08-12 | 2023-02-16 | Celagenex Research (India) Pvt. Ltd. | Oral algal oil based gastro-intestinal tract permeable peptide composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4190646A (en) * | 1975-11-11 | 1980-02-26 | Sloan-Kettering Institute For Cancer Research | Polypeptide compositions and methods |
JPS57169425A (en) * | 1981-04-10 | 1982-10-19 | Eisai Co Ltd | Composition and method for preventing adsorption of secretin |
EP0082481B2 (en) * | 1981-12-23 | 1990-09-12 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
EP0158487B1 (en) * | 1984-04-09 | 1991-08-28 | Takeda Chemical Industries, Ltd. | Stable composition of interleukin-2 |
US4749690A (en) * | 1986-01-27 | 1988-06-07 | Ortho Pharmaceutical Corporation | Treatment of allergy with thymopentin |
US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
-
1990
- 1990-02-20 IT IT19421A patent/IT1240314B/it active IP Right Grant
- 1990-09-12 IL IL95663A patent/IL95663A0/xx unknown
- 1990-09-14 NZ NZ235324A patent/NZ235324A/en unknown
- 1990-09-18 WO PCT/US1990/005303 patent/WO1991004743A1/en active Application Filing
- 1990-09-18 AU AU64467/90A patent/AU6446790A/en not_active Abandoned
- 1990-09-18 BR BR909006934A patent/BR9006934A/pt unknown
- 1990-09-18 HU HU907939A patent/HUT59013A/hu unknown
- 1990-09-18 JP JP2513786A patent/JPH04502017A/ja active Pending
- 1990-09-19 ZA ZA907492A patent/ZA907492B/xx unknown
- 1990-09-25 CA CA002026149A patent/CA2026149A1/en not_active Abandoned
- 1990-09-26 DD DD90344215A patent/DD298053A5/de not_active IP Right Cessation
- 1990-09-27 PT PT95451A patent/PT95451A/pt not_active Application Discontinuation
- 1990-09-27 IE IE347590A patent/IE903475A1/en unknown
- 1990-09-27 EP EP19900310606 patent/EP0420649A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
HU907939D0 (en) | 1991-08-28 |
WO1991004743A1 (en) | 1991-04-18 |
EP0420649A3 (en) | 1991-07-31 |
ZA907492B (en) | 1991-10-30 |
IT1240314B (it) | 1993-12-07 |
JPH04502017A (ja) | 1992-04-09 |
NZ235324A (en) | 1992-07-28 |
CA2026149A1 (en) | 1991-03-29 |
PT95451A (pt) | 1991-05-22 |
IT9019421A1 (it) | 1991-03-29 |
DD298053A5 (de) | 1992-02-06 |
IT9019421A0 (it) | 1990-02-20 |
AU6446790A (en) | 1991-04-28 |
IE903475A1 (en) | 1991-04-10 |
IL95663A0 (en) | 1991-06-30 |
EP0420649A2 (en) | 1991-04-03 |
BR9006934A (pt) | 1991-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT59013A (en) | Process for producing stabilized aqueous compositions of small peptides | |
HUT54037A (en) | Process for producing retarde compositions containing water-soluble peptides | |
HUT46232A (en) | Process for producing compositions containing peptides | |
HUT54046A (en) | Process for producing pharmaceutical compositions | |
EP0428003A3 (en) | Process for the preparation of polyetherglycols | |
HU900041D0 (en) | Process for preparation of thiazole-derivatives | |
HU907113D0 (en) | Process for producing analogues of 2', 3'-didesoxy-2'-fluoro-arabino-nucleoside | |
EP0427965A3 (en) | Process for the preparation of cyclohexanol derivatives | |
HU902995D0 (en) | Process for the preparation of oxophthalazinyl-acetic acid derivatives | |
HU900040D0 (en) | Process for preparation of (pyrrolil-phenyl)-substituted-hydroxamacid-derivatives | |
EP0425930A3 (en) | Process for the preparation of symmetrical diarylacetylenes | |
ZA908686B (en) | Process for manufacture of 1,1-dichlorotetrafluoroethane | |
IL93393A0 (en) | Improved process for the preparation of o-carboxypyridyl-and o-carboxyquinolyl-imidazolinones | |
HU895262D0 (en) | Improved process for the preparation of phenfluramine | |
HU901603D0 (en) | Process for the preparation of fluoro-phenols | |
IL93596A0 (en) | Process for the preparation of n-allylmetatrifluoromethyl-aniline | |
EP0412361A3 (en) | Process for the preparation of 4-methylentetrahydropyran | |
IL95496A0 (en) | Process for the preparation of fluoropyridines | |
EP0415189A3 (en) | Process for the preparation of aminbenzylalcohol | |
HU901260D0 (en) | Process for preparation of bisphenethanolamines | |
HU896744D0 (en) | Process for preparation of intermediers | |
EP0417543A3 (en) | Process for the preparation of 3-methylquinolin-8-carboxylic acid | |
HU900036D0 (en) | Process for preparation of 2,4-diamino-6-pyperidinyl-pyrimidin-3-n-oxide | |
HU896646D0 (en) | Process for the preparation of novel triacontanol derivatives | |
ZA909346B (en) | Process for the preparation of alkylene-bis(2-pyridylamine)compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |